Pharma Journalist 9038 posts 0 comments

Eli Lilly and Company announced a definitive agreement to acquire Disarm Therapeutics, a privately-held biotechnology company creating a new class of disease-modifying therapeutics for…
Read More...

Y-mAbs Therapeutics, Inc. a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the…
Read More...

Nestlé announced the successful completion of its acquisition of Aimmune Therapeutics, Inc. Joining Nestlé Health Science (NHSc) as a stand-alone business unit called Aimmune…
Read More...

Dyno Therapeutics, a biotech company applying artificial intelligence (AI) to gene therapy, announced a collaboration and license agreement with Roche to apply Dyno’s CapsidMap platform…
Read More...

Boehringer Ingelheim and Oxford BioTherapeutics Ltd. (OBT) announced they are building on their successful partnership and are establishing a new alliance to discover additional…
Read More...

Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved…
Read More...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced the…
Read More...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Neogene Therapeutics, Inc., a…
Read More...

HITGEN announces it has entered into a definitive agreement with Ligand Pharmaceuticals Inc. to acquire Vernalis (R&D) Limited, Cambridge, UK-based world leaders in fragment and…
Read More...

Astellas Pharma Inc. and Seagen Inc. announced positive topline results from the second cohort of patients in the pivotal phase 2 single-arm clinical trial known as EV-201. The cohort…
Read More...